CO5690613A2 - Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoporosis - Google Patents
Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoporosisInfo
- Publication number
- CO5690613A2 CO5690613A2 CO05076615A CO05076615A CO5690613A2 CO 5690613 A2 CO5690613 A2 CO 5690613A2 CO 05076615 A CO05076615 A CO 05076615A CO 05076615 A CO05076615 A CO 05076615A CO 5690613 A2 CO5690613 A2 CO 5690613A2
- Authority
- CO
- Colombia
- Prior art keywords
- aryl
- alkyl
- alkylamino
- carbamoyl
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/043—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1.- El uso del compuesto de la fórmula I A-B-X-E-F-K-(D)- TIC-GM-M-FAND#39-I (I)para la producción de productos farmacéuticos para el tratamiento de enfermedades degenerativas de las articulaciones, en la cual:A a1) es un átomo de hidrógeno, (C1-C8)-alquilo, (C1-C8)-alcanoílo, (C1-C8)-alcoxicarbonilo o (C1-C8)-al-quilsulfonilo en los cuales en cada caso 1, 2,ó 3 átomos de hidrógeno están reemplazados opcionalmente por 1, 2 ó 3 radicales idénticos o diferentes del grupo constituido por carboxilo, amino, (C1-C4)-alquilo, (C1-C4)-alquilamino, hidroxilo, (C1--C3)-alcoxi, halógeno, di-(C1-C4)-alquilamino, carbamoílo, sulfamoílo, (C1-C4)-alcoxicarbonilo, (C6-C12)-arilo y (C6-C12)-ariI-(C1-C5)alquilo, o en la cual en cada caso 1 átomo de hidrógeno está reemplazado opcionalmente por un radical del grupo constituido por (C3-C8)-cicloalquilo, (C1-C4)-alquilsulfonilo, (C1-C4)-alquilsulfinilo, (C6-C12)aril-(C1-C4)-alquilsulfonilo, (C6-C12)-aril-(C1-C4)-alquilsulfinilo, (C6-C12)-ariloxi, (C3-C9)-heteroarilo y (C3-C9)-heteroariloxi y 1 ó 2 átomos de hidrógeno están reemplazados por 1 ó 2 radicales idénticos o diferentes del grupo constituido por carboxilo, amino, (C1-C4)-alquilamino, hidroxilo, (C1-C4)-alcoxi, halógeno, di-(C1-C4)-alquilamino, carbamoílo, sulfamoílo, (C1-C4)-alquiloxicarbonilo, (C6-C12)-arilo y (C6-C12)-aril(C1-C5)-alquilo, a2) es (C3-C8)-cicloalquilo, carbamoílo, que puede estar sustituido opcionalmente en el nitrógeno con (C1-C6)-alquilo o (C6-C12)-arilo, (C6-C12)-arilo, (C6-C12)-ariloílo, (C6-C12)-aril-sulfonilo o (C3-C9)heteroarilo o (C3-C9)-heteroariloílo, donde en los radicales definidos en a1) y a2) heteroarilo, ariloílo, arilsulfonilo y heteroariloílo está sustituido opcionalmente en cada caso con 1, 2, 3, ó 4 radicales diferentes del grupo constituido por carboxilo, amino, nitro, hidroxilo, ciano, (C1--C4)-alquilamino, (C1-C4)-alquilo, (C1-C4)-alcoxi, halógeno, di-(C1-C4)alquilamino, carbamoílo, sulfamoílo y (C1-C4)-alcoxicarbonilo, o a3) es un radical de la fórmula II, donde R(1) se define como A en a1) o a2), ...
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10304994A DE10304994A1 (de) | 2003-02-07 | 2003-02-07 | Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5690613A2 true CO5690613A2 (es) | 2006-10-31 |
Family
ID=32797325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05076615A CO5690613A2 (es) | 2003-02-07 | 2005-08-03 | Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoporosis |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1594520B1 (es) |
| JP (1) | JP2006516980A (es) |
| KR (1) | KR20050105447A (es) |
| CN (1) | CN1317029C (es) |
| AR (1) | AR043036A1 (es) |
| AT (1) | ATE335500T1 (es) |
| AU (1) | AU2004210396A1 (es) |
| BR (1) | BRPI0407333A (es) |
| CA (1) | CA2514152C (es) |
| CO (1) | CO5690613A2 (es) |
| CY (1) | CY1105708T1 (es) |
| DE (2) | DE10304994A1 (es) |
| DK (1) | DK1594520T3 (es) |
| ES (1) | ES2268622T3 (es) |
| HK (1) | HK1085926A1 (es) |
| HR (1) | HRP20050701B1 (es) |
| IL (1) | IL169899A0 (es) |
| MA (1) | MA27618A1 (es) |
| ME (1) | MEP41008A (es) |
| MX (1) | MXPA05007310A (es) |
| MY (1) | MY135827A (es) |
| NO (1) | NO333903B1 (es) |
| NZ (1) | NZ541680A (es) |
| PE (1) | PE20040939A1 (es) |
| PL (1) | PL206412B1 (es) |
| PT (1) | PT1594520E (es) |
| RS (1) | RS51029B (es) |
| RU (1) | RU2329057C2 (es) |
| TW (1) | TW200505472A (es) |
| WO (1) | WO2004069266A2 (es) |
| ZA (1) | ZA200505177B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0710522D0 (en) * | 2007-06-01 | 2007-07-11 | Royal Veterinary College The | Drug delivery system comprising matrix metalloproteinase inhibitors |
| IT1391236B1 (it) * | 2008-07-11 | 2011-12-01 | St Luso Farm D'italia Spa | Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
| MX9100717A (es) * | 1990-08-24 | 1992-04-01 | Syntex Inc | Antagonistas de la bradiquinina |
| FR2751650B1 (fr) * | 1996-07-24 | 1998-10-09 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
| CA2364178C (en) * | 2000-12-05 | 2006-01-10 | Yasuhiro Katsu | N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| EP1496835A4 (en) * | 2002-02-01 | 2006-10-18 | Omeros Corp | COMPOSITIONS AND METHODS FOR THE SYSTEMIC SUPPRESSION OF CARTON DECOMPOSITION |
-
2003
- 2003-02-07 DE DE10304994A patent/DE10304994A1/de not_active Withdrawn
-
2004
- 2004-01-13 PE PE2004000064A patent/PE20040939A1/es not_active Application Discontinuation
- 2004-01-23 WO PCT/EP2004/000550 patent/WO2004069266A2/de active IP Right Grant
- 2004-01-23 KR KR1020057014116A patent/KR20050105447A/ko not_active Application Discontinuation
- 2004-01-23 PL PL376605A patent/PL206412B1/pl unknown
- 2004-01-23 DK DK04704552T patent/DK1594520T3/da active
- 2004-01-23 JP JP2006501585A patent/JP2006516980A/ja active Pending
- 2004-01-23 CA CA2514152A patent/CA2514152C/en not_active Expired - Fee Related
- 2004-01-23 AU AU2004210396A patent/AU2004210396A1/en not_active Abandoned
- 2004-01-23 CN CNB2004800034498A patent/CN1317029C/zh not_active Expired - Fee Related
- 2004-01-23 ES ES04704552T patent/ES2268622T3/es not_active Expired - Lifetime
- 2004-01-23 BR BR0407333-9A patent/BRPI0407333A/pt not_active IP Right Cessation
- 2004-01-23 DE DE502004001159T patent/DE502004001159D1/de not_active Expired - Lifetime
- 2004-01-23 AT AT04704552T patent/ATE335500T1/de active
- 2004-01-23 RU RU2005127862/15A patent/RU2329057C2/ru not_active IP Right Cessation
- 2004-01-23 ME MEP-410/08A patent/MEP41008A/xx unknown
- 2004-01-23 RS YUP-2005/0565A patent/RS51029B/sr unknown
- 2004-01-23 EP EP04704552A patent/EP1594520B1/de not_active Expired - Lifetime
- 2004-01-23 PT PT04704552T patent/PT1594520E/pt unknown
- 2004-01-23 NZ NZ541680A patent/NZ541680A/en not_active IP Right Cessation
- 2004-01-23 MX MXPA05007310A patent/MXPA05007310A/es active IP Right Grant
- 2004-02-05 TW TW093102562A patent/TW200505472A/zh unknown
- 2004-02-05 AR ARP040100363A patent/AR043036A1/es unknown
- 2004-02-06 MY MYPI20040362A patent/MY135827A/en unknown
-
2005
- 2005-06-27 ZA ZA200505177A patent/ZA200505177B/en unknown
- 2005-07-26 IL IL169899A patent/IL169899A0/en unknown
- 2005-08-03 CO CO05076615A patent/CO5690613A2/es not_active Application Discontinuation
- 2005-08-04 HR HRP20050701AA patent/HRP20050701B1/hr not_active IP Right Cessation
- 2005-08-05 MA MA28425A patent/MA27618A1/fr unknown
- 2005-09-06 NO NO20054144A patent/NO333903B1/no not_active IP Right Cessation
-
2006
- 2006-05-25 HK HK06106009A patent/HK1085926A1/xx not_active IP Right Cessation
- 2006-10-16 CY CY20061101482T patent/CY1105708T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP056194A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa | |
| TW200613243A (en) | Novel compounds | |
| CY1113306T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
| EA200802390A1 (ru) | Конъюгаты аналогов азиридилэпотилона и фармацевтические композиции, содержащие их | |
| NO20073628L (no) | Pyridoner som er nyttige som inhibitorer av kinaser | |
| ECSP055853A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos | |
| AR049126A1 (es) | Derivados de 5, 6, 7, 8 - tetrahidroimidazo[1,5a]piridina con actividad inhibitoria de la aldosterona sintasa, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento del hiperaldosterismo y del sindrome de cushing. | |
| ECSP105253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| AR044923A1 (es) | Imidazoquinolinas sustituidas con sulfonamida | |
| TW200505453A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| ECSP034744A (es) | Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos | |
| TW200510297A (en) | Substituted n-aryl heterocycles, process for their preparation and their use as medicaments | |
| MXPA05005296A (es) | Bis-aril sulfonamidas. | |
| DK2324008T3 (da) | Diarylpyrazol som protein kinase inhibitorer | |
| ATE485269T1 (de) | C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden | |
| MXPA05010210A (es) | Inhibidores no nucleosidos de transcriptasa inversa para tratar las enfermedades mediadas por el virus de la inmunodeficiencia humana (vih). | |
| DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
| ATE502924T1 (de) | Lineare harnstoffmimetika-antagonisten des p2y1- rezeptors zur behandlung von thromboseleiden | |
| UY27685A1 (es) | Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso | |
| NO20070502L (no) | Azaindoler nyttige som inhibitorer av proteinkinaser | |
| CY1118570T1 (el) | Νεα συνθεση αλφαιντανυλης για την αγωγη του οξεος πονου | |
| NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner | |
| BRPI0509667B8 (pt) | composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto | |
| ATE447575T1 (de) | Selektive spirocyclische glucocorticoid-rezeptor- modulatoren | |
| CO5690613A2 (es) | Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoporosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |